Results of the Turkish prospective multi-center study utilizing the 21-gene Oncotype DX assay: Decision impact analysis.

Ozmen, VahitAtasoy, AjlanGokmen, ErhanOzdogan, MustafaGuler, Emine NiluferUras, CihanOk, Engin2024-04-242024-04-2420150732-183X1527-7755https://doi.org/10.1200/jco.2015.33.15_suppl.e11515https://hdl.handle.net/11468/18286Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer -- MAY 29-JUN 02, 2015 -- Chicago, IL[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Results of the Turkish prospective multi-center study utilizing the 21-gene Oncotype DX assay: Decision impact analysis.Results of the Turkish prospective multi-center study utilizing the 21-gene Oncotype DX assay: Decision impact analysis.Conference Object3315WOS:00035803690214310.1200/jco.2015.33.15_suppl.e11515Q1